Skip to content
10-Q

Quarterly Report

NewGen BioPharma Corp.

0001640334-16-000831

← back to feed
Filed
Mar 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Mar 15, 2016 11.9M sh
Capex Q1 2016 · Jan 31, 2016 $0
Capex Q1 2016 · Jan 31, 2015 $0
Stockholders Equity Q1 2016 · Jan 31, 2016 −$94.59K
Stockholders Equity Q1 2016 · Oct 31, 2015 −$83.31K
Total Liabilities Q1 2016 · Jan 31, 2016 $94.59K
Total Liabilities Q1 2016 · Oct 31, 2015 $83.31K
Sga Expense Q1 2016 · Jan 31, 2015 $1.55K
Net Income Q1 2016 · Jan 31, 2015 −$10.18K
Operating Income Q1 2016 · Jan 31, 2015 −$10.18K
Stock Issued Q1 2016 · Oct 31, 2013 2.9M sh
Stock Issued Q1 2016 · Feb 28, 2011 9M sh